|
|
|
By Allison Proffitt
October 8, 2009 | Using a new technique, researchers revealed the first complete view of the 3-D structure of the genome and the way chromosomes arrange themselves in the nucleus. The work was done by scientists at Harvard University, the Broad Institute of Harvard and MIT, University of Massachusetts Medical School, and the Massachusetts Institute of Technology, and published in Science.
The technology, explains Job Dekker, associate professor of biochemistry and molecular pharmacology at UMass Medical School and a senior author of the paper, was built on an existing technology that had previously been applied to only two loci, but in this case was applied to the whole genome.
Co-first author Nynke van Berkum, a postdoctoral researcher at UMass Medical School in Dekker's laboratory, explains the process. “We grow cells and we crosslink the cells using formaldehyde so chromatin that are close to each other link, then we fragment the DNA… What happens is you get these molecules in your solution that are crosslinked to each other representing two fragments that were originally close to each other in the nucleus.”
The team used Illumina paired end sequencing to reconstruct the genome from these neighboring fragments and determine the original shape. “This generates an enormous dataset that tells us what the neighbors are at any different loci,” says Dekker. “No optical methods were used to look at the chromosomes.”
Co-first author Erez Lieberman-Aiden, a graduate student in the Harvard-MIT Division of Health Science and Technology and a researcher at Harvard's School of Engineering and Applied Sciences and in the laboratory of Eric Lander at the Broad Institute, lead the computational efforts.
“A long standing question has been how do you fit such a long genome in a tiny nucleus in a way that’s still functional? How do you solve that problem so that it’s biologically active?” Dekker tells Bio-IT World, and he calls the findings “very surprising and very different from what people have thought before.”
The results of the new technology showed that active and gene-rich portions of chromosomes are segregated from inactive portions. “One compartment has all the active stuff and the other compartment has the inactive stuff. The cell can focus on the active parts while ignoring the inactive parts,” says Dekker.
Within the two compartments, the chromosomes aren’t a tangled, knotted mess, but organized in a way Dekker calls, “very dense but very efficient… It’s a really beneficial way of packing. If you want to unfold a little section that you want to access, you can effectively just unfold that section. Very convenient.”
“The technique allows us to look at the whole genome all at once,” says van Berkum. “It’s a huge improvement to anything that’s around at this point. Looking at the whole genome and looking at different processes like differentiation of cells, cells in the cell cycle, now that we can see the whole genome at once we can see what’s really happening.”
Dekker was equally enthusiastic about the future applications of the work and believes it will shift genome research from a linear approach—simply reading genetic code—to a spatial approach considering genes’ proximities to each other and locations in the genome as a whole, an approach he believes will inform gene regulation. “I suspect in the next one or two years we’ll be able to get much higher resolution pictures of whole genomes and its going to help us understand better how genomes function.”
Turning Genomics Data into Practical Insight With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can: - Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines.
- Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image).
Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands.
New Complimentary Market Survey… Collaborations and Communications Within Drug Discovery Research This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns. An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
Scientific Software Engineer Boston MA $70,000 to $95,000
Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET.
Apply at http://jobs.tessella.com
Early Access Collaborations Managers Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes. As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers. This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions. It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply
Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules. It is therefore suitable for use in a variety of markets including scientific research and clinical applications. As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team. The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market. This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company. Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial leadership, who wish to apply a fresh approach to existing markets. Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries. We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products. Click to Apply
|
|
|